Tesla CEO Elon Musk on Friday once again supported Ozempic and other "miracle weight-loss drugs", saying that the health risks caused by obesity certainly outweigh the risks posed by weight-loss drugs.
Musk posted on his social media platform X, "I can't imagine that the diet drug Ozempic has really affected Walmart's food sales. While no drug is without side effects, the health pitfalls associated with obesity almost certainly outweigh the risks of GLP-1 receptor agonists."
John Furner, CEO of Walmart's U.S. operations, said in an interview this week that the company has seen an impact on food-shopping demand from people taking the diabetes drugs Ozempic, Wegovy and other appetite-suppressing drugs.
Furner said, "We did see a slight change compared to the total population, and we did see a slight drop in the overall shopping basket. A little bit less stuff to buy, a little bit less calories."
Explore Faxne products: Injection Pens | Glass Cartridges | TCM Herbs
Medical Disclaimer
The information provided in this article is for general informational and educational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting, stopping, or modifying any medication, supplement, or treatment regimen.
The products mentioned on faxne.com are medical devices and health-related products intended for use under professional supervision. Individual results may vary. References to specific medications (including but not limited to insulin, GLP-1 receptor agonists, HGH, and related therapies) are for informational context only and do not constitute endorsement or prescription.
faxne.com does not claim that any product can diagnose, treat, cure, or prevent any disease. If you have a medical emergency, contact your local emergency services immediately.
